JosephEdwardPalascakMD

PubMed

• 15 citations
  Efficacy and safety of protein C concentrate to treat purpura fulminans and thromboembolic events in severe congenital protein C deficiency.
  Marilyn J. Manco-Johnson, Lisa Bomgaars, J. E. Palascak, Amy D. Shapiro, John Geil, Sandor Fritsch, Borislava G. Pavlova, David Gelmont> ;Thrombosis and Haemostasis. 2016 Jul 4
• Viral dynamic modelling of Hepatitis C and resistance-associated variants in haemophiliacs.
  Kenneth E. Sherman, R. Ke, Susan D. Rouster, Enass A. Abdel-hameed, C. Park, J. E. Palascak, Alan S. Perelson> ;Haemophilia. 2016 Jul 1
• 3 citations
  VWD type 2N (Normandy) in two sisters
  J. L. Agne, N. Ahmad, J. E. Palascak, R. Khaled, Nagla Abdel Karim> ;Haemophilia. 2015 May 1
• 25 citations
  Prevalence of conditions associated with human immunodeficiency and hepatits virus infections among persons with haemophilia, 2001-2003
  James J. Goedert, Jaime Siegel, Kay Miller, Michael M. Lederman, Alexis A. Thompson, Brittan Browning, Susan Gamerman, Kevin McRedmond, Janice S. Withycombe, Ralph A. ...> ;Haemophilia. 2005 Sep 1
• 144 citations
  Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
  Rekha Parameswaran, Amy D. Shapiro, Joan Cox Gill, Craig M. Kessler, Thomas C. Abshire, Anne L. Angiolillo, Lisa N. Boggio, Alan R. Cohen, Donna DiMichele, W. Hanna, K...> ;Haemophilia. 2005 Mar 1
• 37 citations
  Light-chain paraproteins with lupus anticoagulant activity
  Zahida Yasin, Donald Quick, Perumal Thiagarajan, Denise Spoor, Juan Caraveo, J. E. Palascak> ;American Journal of Hematology. 1999 Oct 1
• Sickle Cells Modified by an Osmotic Pulse in the Presence of Inositol Hexaphosphate Have Decreased Intracellular Hemoglobin Concentration and Decreased in Vitro Sickli...
  Robert S. Franco, Robin Barker-Gear, Edward B. Silberstein, Gayle Mayfield, Murray Weiner, J. E. Palascak, Ralph Green> ;Advances in Experimental Medicine and Biology. 1992 Jan 1
• 49 citations
  Functional and metabolic properties of human asialofibrinogen.
  Jose Martinez, C. L. Peters> ;The Journal of Laboratory and Clinical Medicine. 1977 Feb 1
• 3 citations
  Successful administration of iron dextran in a patient who experienced a life threatening reaction to intravenous iron dextran.
  Martha A Hickman, I. Leonard Bernstein, J. E. Palascak> ;Annals of Allergy, Asthma & Immunology. 2000 Feb 1
• 77 citations
  Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease.
  Jose Martinez, D. Kwasniak> ;The Journal of Clinical Investigation. 1978 Feb 1
• 1 citations
  Proceedings: Functional and metabolic studies of human asialofibrinogen.
  Jose Martinez, C. L. Peters> ;Thrombosis Et Diathesis Haemorrhagica. 1975 Sep 30
• 7 citations
  Anti-factor VIII anamnesis after factor IX complex.
  S R Shapiro> ;The New England Journal of Medicine. 1977 Dec 22
• 71 citations
  Dysfibrinogenemia associated with liver disease.
  Jose Martinez> ;The Journal of Clinical Investigation. 1977 Jul 1
• 2 citations
  Platelet kinetics in autosomal dominant macrothrombocytopenia
  Allan J. Erslev, J. E. Palascak, Bahu S. Shaikh, Jose Martinez> ;The Journal of Laboratory and Clinical Medicine. 1998 Jun 1
• 79 citations
  The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains
  Jose Martinez, Karen A. MacDonald, J. E. Palascak> ;Blood. 1983 Jun 1
• 3 citations
  Prothrombin complex concentrates in hemophiliacs with inhibitors--a multicenter therapeutic trial.
  S. S. Shapiro, A. V. Rao, P. H. Levine, P. M. Blatt, > ;Transactions of the Association of American Physicians. 1980 Jan 1
• 211 citations
  Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.
  S. S. Shapiro, J. E. Palascak, A. V. Rao, P. H. Levine, P. M. Blatt> ;The New England Journal of Medicine. 1980 Aug 21
• 23 citations
  THE ABNORMAL CARBOHYDRATE COMPOSITION OF THE DYSFIBRINOGENEMIA ASSOCIATED WITH LIVER DISEASE
  Jose Martinez, P. M. Keane, P. B. Gilman, J. E. Palascak> ;Annals of the New York Academy of Sciences. 1983 Jun 1
• 23 citations
  A modified SDS agarose gel method for determining factor VIII von Willebrand factor multimers using commercially available reagents.
  Mary Ann Miller, J. E. Palascak, Michael Thompson, Orlando J. Martelo> ;Thrombosis Research. 1985 Sep 15
• Platelet Dysfunction and Bleeding Associated with β-Lactam Antibiotics: Reply
  Orlando J. Martelo, J. E. Palascak> ;The Journal of Infectious Diseases. 1988 May 1
• 25 citations
  Warfarin resistance associated with intravenous lipid administration
  Dave M. Lutomski, J. E. Palascak, Robert H. Bower> ;JPEN. Journal of Parenteral and Enteral Nutrition. 1987 May 1
• 2 citations
  Fat emulsion effects on prothrombin time in warfarin anticoagulated patients: an in vitro study
  MA Cotto, Dave M. Lutomski, J. E. Palascak, WK Fant, RJ LaFrance> ;JPEN. Journal of Parenteral and Enteral Nutrition. 1990 Mar 1
• Join now to see all